Article
Adenosine Kinase: An Epigenetic Modulator and Drug Target
1 May 2025
Abstract excerpt
Adenosine kinase (ADK, EC: 2.7.1.20) is an evolutionarily ancient ribokinase, which acts as a metabolic regulator by transferring a phosphoryl group to adenosine to form AMP. The enzyme is of interest as a therapeutic target because its inhibition is one of the most effective means to raise the levels of adenosine and hence adenosine receptor activation. For these reasons, ADK has received significant attention...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
